Why pharma must socialise the science at congress

Author:

Andrew Moore, Client Engagement Director, Inizio Engage XD

Medical congresses continue to play a central role in scientific exchange, professional growth and peer-to-peer connection. They convene clinicians around emerging data, developing evidence and shared clinical challenges.

Yet, in many cases, the science presented is still approached as something to be communicated, rather than something to be collectively examined and interpreted.

As expectations rise and attention becomes harder to earn, one-way content delivery struggles to translate evidence into understanding. Data may be presented clearly, but without discussion, challenge and interpretation, its impact is often short-lived. The real opportunity for pharmaceutical companies lies in socialising the science, creating environments where evidence is explored collectively and meaning is built through interaction.

What the evidence consistently shows

The IPCAA and Emota HCP Congress Experience research is clear on where healthcare professionals derive the most value at congress.

The highest-rated professional development activities are rooted in peer-to-peer exchange. Expert-led panels, interactive case-based workshops and networking with peers consistently outperform passive lecture formats. These settings allow clinicians to compare practice, interrogate data and learn from real-world experience rather than absorb information in isolation.

Engagement data reinforces this pattern. Live Q&A and “ask the expert” sessions are rated as the most engaging formats delivered by pharmaceutical companies. Healthcare professionals repeatedly call for more time for discussion during sessions. In industry-sponsored symposia specifically, time for questions and discussion is one of the strongest drivers of perceived value, alongside practical clinical application and interactive elements.

The message is consistent. Interaction is not an enhancement to scientific content. It is how scientific value is realised.

Human interaction is the point of congress

Despite growing interest in digital and AI-enabled tools, healthcare professionals continue to place the greatest value on face-to-face interaction. Technology is welcomed when it supports better dialogue, not when it replaces it.

This positions congress as a uniquely human learning environment. Trust, credibility and relevance are built through conversation, not transmission. Networking is not a peripheral activity. It is a core outcome of congress attendance and a primary way scientific insights are validated and absorbed.

Interaction is not what happens after learning. It is how learning happens.

Why formats must evolve

The evidence points to a clear need to redesign educational engagements around interaction.

Long, presentation-heavy sessions restrict dialogue and limit perceived value. In contrast, shorter, discussion-led formats such as panels, roundtables, meet-the-expert sessions and case-based discussions better reflect how healthcare professionals want to learn and engage.

Real-world patient case studies are particularly powerful. They allow clinicians to contextualise data, challenge assumptions and explore how evidence applies to everyday clinical decisions. When science is positioned as a shared problem-solving exercise, it becomes more memorable, more credible and more impactful.

Socialised science is also measurable science

Interactive, socially enabled formats do more than improve experience. They generate insight.

Live polling, audience questions, case-path choices and feedback tools surface knowledge gaps, clinical priorities and decision drivers in real time. This transforms congress engagements from static presentations into measurable learning environments that inform future content, strategy and follow-up.

When designed intentionally, social interaction becomes a source of understanding for both healthcare professionals and organisations.

The risk of standing still

When scientific engagement remains one-directional, congress activity becomes less engaging, less differentiated and less effective.

Healthcare professionals see less value when sessions feel overly didactic or promotional. Opportunities to build trust, support learning and capture meaningful insight are missed. Over time, this may erode both educational impact and the perceived value of industry participation.

Standing still does not preserve credibility. It gradually weakens it.

Why socialising the science is now a strategic decision

When science is socialised, congress becomes more than a venue for information exchange. It becomes a shared learning environment where evidence is tested, contextualised and made actionable.

Pharmaceutical companies that continue to rely on presentation-led formats risk limiting the impact of even their strongest data. Those that design for dialogue extend learning, strengthen credibility and support more confident clinical decision-making.

In a congress environment defined by limited attention and rising expectations, socialising the science is not a stylistic choice. It is a strategic decision about whether scientific engagement leads to understanding or simply exposure.